The components of Hericium erinaceus mycelium ameliorate Alzheimer’s disease-related pathologies in metabolically stressed APP/PS1 mice
碩士 === 國立陽明大學 === 生物藥學研究所 === 107 === Alzheimer's disease (AD) is a neurodegenerative disease and the most common type of dementia, and metabolic syndrome is regarded as one of the risk factors for AD pathogenesis. In our previous study, we have successfully established a metabolically stressed...
Main Authors: | Kuan-Wei Wu, 伍冠維 |
---|---|
Other Authors: | Young-Ji Shiao |
Format: | Others |
Language: | zh-TW |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/a7zz6d |
Similar Items
-
The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer’s Disease-Related Pathologies in APP/PS1 Transgenic Mice
by: Tsai-Teng Tzeng, et al.
Published: (2018-02-01) -
Investigating the therapeutic potential of Hericium erinaceus mycelium on Alzheimer's disease
by: Tsai-Teng Tzeng, et al.
Published: (2016) -
Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium
by: I-Chen Li, et al.
Published: (2014-01-01) -
The role of hericium erinaceus mycelium on cytoskeleton reorganization in activated microglia
by: LAI, CHANG-MEI, et al.
Published: (2017) -
Array of Metabolites in Italian <i>Hericium erinaceus</i> Mycelium, Primordium, and Sporophore
by: Federica Corana, et al.
Published: (2019-09-01)